Receptors, Fibroblast Growth Factor
"Receptors, Fibroblast Growth Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.
| Descriptor ID |
D017468
|
| MeSH Number(s) |
D12.776.543.750.750.400.370
|
| Concept/Terms |
Receptors, Fibroblast Growth Factor- Receptors, Fibroblast Growth Factor
- Receptors, FGF
- Fibroblast Growth Factor Receptor
- Fibroblast Growth Factor Receptors
- FGF Receptor
- Receptor, FGF
- FGF Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Fibroblast Growth Factor".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Fibroblast Growth Factor".
- Receptors, Fibroblast Growth Factor
- Receptor, Fibroblast Growth Factor, Type 1
- Receptor, Fibroblast Growth Factor, Type 2
- Receptor, Fibroblast Growth Factor, Type 3
- Receptor, Fibroblast Growth Factor, Type 4
- Receptor, Fibroblast Growth Factor, Type 5
This graph shows the total number of publications written about "Receptors, Fibroblast Growth Factor" by people in this website by year, and whether "Receptors, Fibroblast Growth Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 4 | 1 | 5 |
| 2004 | 4 | 1 | 5 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 0 | 3 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Fibroblast Growth Factor" by people in Profiles.
-
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. Cell Oncol (Dordr). 2022 Feb; 45(1):41-56.
-
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments. Int J Mol Sci. 2020 Mar 16; 21(6).
-
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910.
-
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling. Cancer Cell. 2017 10 09; 32(4):474-489.e6.
-
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial. J Natl Cancer Inst. 2017 05 01; 109(5).
-
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties. Oncogene. 2014 Jun 26; 33(26):3411-21.
-
E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-? in the bone microenvironment. Proc Natl Acad Sci U S A. 2013 Apr 30; 110(18):7336-41.
-
The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation. Hum Mol Genet. 2013 Aug 01; 22(15):3048-62.
-
Drosophila Zpr1 (Zinc finger protein 1) is required downstream of both EGFR and FGFR signaling in tracheal subcellular lumen formation. PLoS One. 2012; 7(9):e45649.
-
Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Mol Cancer Ther. 2012 Mar; 11(3):690-9.